An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
A legfontosabb adatok
- Hol
- Beverly Hills, Birmingham, Boston, Cleveland, Fairway, Jacksonville, Kansas City, New York, Philadelphia, Scottsdale és St Louis (Egyesült Államok)Mind a 20 helyszín megnézése
- Fázis
- 2. fázis
Helyszínek itt: Egyesült Államok
- Attune Health Research IncBeverly Hills, Egyesült ÁllamokNo longer taking part
- University of Alabama at BirminghamBirmingham, Egyesült ÁllamokNo longer taking part
- University of Alabama at Birmingham - Department of DermatologyBirmingham, Egyesült ÁllamokNo longer taking part
- Brigham & Women's HospitalBoston, Egyesült ÁllamokNo longer taking part
- Brigham and Women's Hospital - CTHBoston, Egyesült ÁllamokNo longer taking part
- Cleveland Clinic FoundationCleveland, Egyesült ÁllamokNo longer taking part
- KU Clinical Research Center - Clinical and Translational Science Unit (CTSU)Fairway, Egyesült ÁllamokNo longer taking part
- Mayo Clinic in FloridaJacksonville, Egyesült ÁllamokNo longer taking part
- KU Clinical and Translational Science Unit (CTSU) RainbowKansas City, Egyesült ÁllamokNo longer taking part
- University of Kansas Medical CenterKansas City, Egyesült ÁllamokNo longer taking part
- Icahn School of Medicine at Mount SinaiNew York, Egyesült ÁllamokNo longer taking part
- Mount Sinai Doctors DermatologyNew York, Egyesült ÁllamokNo longer taking part
- NYU Grossman School of Medicine, The Ronald O. Perelman Department of DermatologyNew York, Egyesült ÁllamokNo longer taking part
- NYU Langone Health Clinical Research CenterNew York, Egyesült ÁllamokNo longer taking part
- NYU Langone Radiology - Ambulatory Care Center East 41st StreetNew York, Egyesült ÁllamokNo longer taking part
- Center for Human Phenomic SciencePhiladelphia, Egyesült ÁllamokNo longer taking part
- University of Pennsylvania, Perelman Center for Advanced Medicine (PCAM)Philadelphia, Egyesült ÁllamokNo longer taking part
- Mayo ClinicScottsdale, Egyesült ÁllamokNo longer taking part
- Center for Outpatient HealthSt Louis, Egyesült ÁllamokNo longer taking part
- Washington University School of MedicineSt Louis, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Pfizer
- Azonosító
- NCT05192200
- A regiszteradat frissítve
- 2025. február 6.
- Eredeti leírás
The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.A teljes eredeti leírásKevesebb
AN OPEN LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE SAFETY OF PF-06823859 ADMINISTERED TO ADULT PARTICIPANTS ≥18 AND ≤80 WITH ACTIVE DERMATOMYOSITIS.
The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.
Bevonási feltételek: Participants aged ≥18 and ≤80 with moderate to severe dermatomyositis (DM), that have completed the treatment period of a qualifying study; Capable of giving signed informed consent; Participants who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures.
Kizáró feltételek: Other medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study; Participants who met discontinuation criteria at any point during the participating qualifying studies; Participants with an ongoing safety event in the qualifying studies which, in the opinion of the investigator or sponsor, is an ongoing safety concern OR the participant has met safety monitoring criteria in the qualifying study that has not resolved.